Home -> Law Blog Directory -> Patent Law Blogs -> Patent Baristas
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent BaristasBiotech Patents: How To Face New Challenges
By Stephen Albainy-Jenei
The American Conference Institute?s 10th Advanced Forum on Biotech Patents: Analysis, Insights and Strategies for New Challenges in Biotech Patent Practices will be held at the Royal Sonesta Hotel, Boston, MA, on September 15-16.
At the conference, I will be on a panel discussion with Michele Cimbala, of Sterne, Kessler, Goldstein & Fox, entitled “Life on the Patent Tightrope: Updates on the Proposed Rules and Patent Reform.”
This looks to be a great conference on all the issues in biotech. The ACI Biotech Patent Conference is billed as the ONE place biotech patent practitioners come to learn and discuss the most recent and vital changes facing the industry today:
As a result of developments in the patent world as a whole, the majority of biotechnology companies and their patent agents and attorneys have been in a holding pattern of sorts for the past year, trying to position themselves and their clients in the best possible situation for whatever blows the industry takes … Keeping on top of all of these changes while still advancing the next stage of products from biotechnology has never been more crucial.
Topics include:
- How will the decision in Tafas v. Dudas impact patent practices and what you can expect in the future?
- KSR, In re Kubin, In re MedImmune, In re Duel and other crucial cases: how these court decisions are being interpreted and applied by the USPTO and the Board of Patent Appeals and Interference
- The status of Follow-On Biologics: the European Patent Office has already taken steps to introduce them into the marketplace.With growing demand for generic products in the US, can the FDA and USPTO be far behind?
- As the USPTO continues to implement international patenting approval programs in conjunction with other nations, how do you implement global patent goals and standards into your patent practice?
- The essential skills needed to develop and prosecute an effective patent while avoiding questions of inequitable conduct, overbroad patents, and more.
Speakers include the venerable Hal Wegner and Patent Docs‘ Kevin Noonan. Register by calling 888.224.2480 or registering online.
Let me know if you are interested in attending, anyone who attends the conference as a referral from us is entitled to $200 off the registration price. Just drop me a line for the keycode. Otherwise, I look forward to seeing you in Boston.
Full post as published by Patent Baristas on September 02, 2008 (boomark / email).
Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.
Sunscreen Manufacturers Face Class Actions over Misleading Advertising
Banana Boat, Coppertone Face Class Action in Canada
Estate Planners Face Elder Abuse Class Action
California Estate Planners Face Elder Abuse Class Action
AT&T, Apple Face Potential Class Action over iPhone MMS
AT&T, Apple Face Potential Class Action over iPhone MMS
Florida Cement and Concrete Producers Face Price-Fixing Class Action
Florida Cement and Concrete Producers Face Price-Fixing Class Action
Medicaid Fraud
GSK and Novartis Face $800 Million in Penalties

ACI "Biotech Patents" Conference, Boston, September 15-16
C5 Biotech Patenting Conference
ACI Biotech Patents Conference
Slashdot Discusses Trade Secrets Superseding Patent Law
Cellectis and Regeneron Resolve Licensing Dispute
BIOTECH INDUSTRY CAN BE BENEFITED IF THE TRADE SECRETS ARE USED IN TANDEM WITH THE PATENT PROTECTION








